Lung squamous cell carcinoma (SCC) is the second most prevalent type of lung cancer. Currently, no targeted therapeutics are approved for treatment of this cancer, largely because of a lack of systematic understanding of the molecular pathogenesis of the disease. To identify therapeutic targets and perform comparative analyses of lung SCC, we probed somatic genome alterations of lung SCC by using samples from Korean patients
Background: Lung cancer is the world's leading cause of cancer mortality. The main factors contribu...
The underlying genetic alterations for squamous cell carcinoma (SCC) and adenocarcinoma (AC) carcino...
IntroductionThe information regarding therapeutically relevant genomic alterations in small cell lun...
Lung squamous cell carcinoma (SCC) is the second most prevalent type of lung cancer. Currently, no t...
Lung squamous cell carcinoma (lung SqCC) is a common type of lung cancer, causing approximately 400,...
Squamous cell lung cancer causes approximately 400,000 deaths worldwide per year. Identification of ...
Lung squamous cell carcinoma is a common type of lung cancer, causing approximately 400,000 deaths p...
Squamous cell lung cancer causes approximately 400,000 deaths worldwide per year. Identification of ...
Lung cancer is one of the leading causes of death globally.1 Tobacco smoking causes nearly 90% of lu...
The treatment of Lung adenocarcinoma (LUAD) could benefit from the incorporation of precision medici...
Background/aim: In recent years, the genomic landscape of neuroendocrine tumors (NETs) of the lung h...
Lung cancer is one of the most common cancers with high mortality and is described as one of the lea...
Squamous cell carcinoma (SCC) of the lung kills over 350,000 people annually worldwide, and is the m...
AbstractLung cancer causes more deaths, worldwide, than any other cancer. Several histologic subtype...
Lung cancer is the leading cause of cancer-related mortality and will affect ∼6% of the population. ...
Background: Lung cancer is the world's leading cause of cancer mortality. The main factors contribu...
The underlying genetic alterations for squamous cell carcinoma (SCC) and adenocarcinoma (AC) carcino...
IntroductionThe information regarding therapeutically relevant genomic alterations in small cell lun...
Lung squamous cell carcinoma (SCC) is the second most prevalent type of lung cancer. Currently, no t...
Lung squamous cell carcinoma (lung SqCC) is a common type of lung cancer, causing approximately 400,...
Squamous cell lung cancer causes approximately 400,000 deaths worldwide per year. Identification of ...
Lung squamous cell carcinoma is a common type of lung cancer, causing approximately 400,000 deaths p...
Squamous cell lung cancer causes approximately 400,000 deaths worldwide per year. Identification of ...
Lung cancer is one of the leading causes of death globally.1 Tobacco smoking causes nearly 90% of lu...
The treatment of Lung adenocarcinoma (LUAD) could benefit from the incorporation of precision medici...
Background/aim: In recent years, the genomic landscape of neuroendocrine tumors (NETs) of the lung h...
Lung cancer is one of the most common cancers with high mortality and is described as one of the lea...
Squamous cell carcinoma (SCC) of the lung kills over 350,000 people annually worldwide, and is the m...
AbstractLung cancer causes more deaths, worldwide, than any other cancer. Several histologic subtype...
Lung cancer is the leading cause of cancer-related mortality and will affect ∼6% of the population. ...
Background: Lung cancer is the world's leading cause of cancer mortality. The main factors contribu...
The underlying genetic alterations for squamous cell carcinoma (SCC) and adenocarcinoma (AC) carcino...
IntroductionThe information regarding therapeutically relevant genomic alterations in small cell lun...